Group 1 - The Zheng family, one of Hong Kong's "Four Great Families," has a history spanning over a century, with core businesses in real estate, hotels, and jewelry, including New World Group and Chow Tai Fook Jewelry Group [1][3] - Zheng Zhigang, the grandson of the founder Zheng Yutong, has stepped down from all positions in the family business, citing a desire to focus on public service and personal matters [1][6] - Following his resignation as CEO of New World Development, the company reported a significant loss of approximately HKD 19.683 billion for the fiscal year 2024, marking its first loss in nearly 20 years [6][7] Group 2 - Zheng Zhigang has announced his entry into the short drama industry and continues to promote the development of family offices in Hong Kong as the chairman of the Hong Kong Wealth Preservation Academy [2][19] - In collaboration with JAKOTA Capital, Zheng Zhigang is investing USD 100 million to support short drama companies and related projects, with plans to start operations in March 2025 [7][8] - The Zheng family has established a family office to oversee a diversified global investment portfolio, with a new CEO office structure that includes three co-CEOs [18][19] Group 3 - The succession dynamics within the Zheng family are evolving, with Zheng Jiapun emphasizing the importance of finding a capable successor and considering external recruitment if necessary [9][16] - Zheng Zhigang's brother, Zheng Zhiming, has taken on a leadership role in New Creation, while Zheng Zhigang's younger brother, Zheng Zhilang, has also assumed significant responsibilities within the family business [14][18] - The family is focusing on a governance structure that includes family members, professional managers, and experts to ensure effective decision-making [10][16]

Group 1 - The company, New World Development, has acknowledged media speculation regarding potential capital injection from its controlling shareholder and third-party investors, but clarified that it has not received any formal proposals related to this matter [3] - The company is currently in discussions for a loan financing arrangement led by Deutsche Bank AG as part of its routine financing activities [3] - After making reasonable inquiries, the company confirmed that it is not aware of any information that must be disclosed to prevent the creation of a false market for its securities [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00017 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 2,516,633,171 | | 0 | | 2,516,633,171 | | 增加 / 減少 (-) | | | 0 | | | | | | 本月底結存 | | | 2,516,633,171 | | 0 | | 2,516,633,171 | 第 2 頁 共 10 頁 v 1.1.1 | 截至月份: | 2025年8月31日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有 ...

Market Performance - The Hang Seng Index closed at 25,617, up 2.15% for the day and up 27.70% year-to-date [1] - The Hang Seng Tech Index rose 2.20% to 5,798, with a year-to-date increase of 29.79% [1] - The Shanghai Composite Index increased by 0.46% to 3,875, with a year-to-date rise of 15.63% [1] Currency and Commodity Overview - The Renminbi Index stood at 96.570, showing a 0.90% increase over the last month but a 3.33% decline over six months [2] - Brent crude oil price was $68.170 per barrel, down 0.86% over the last month and down 2.68% over six months [2] - Gold prices increased by 3.26% over the last month, reaching $3,473.27 per ounce, and rose 20.07% over six months [2] Company News - Alibaba's stock surged by 18.50% to HKD 137.10 after several major banks raised their target prices following the company's earnings report [5][21] - The pharmaceutical sector saw significant gains, with CSPC Pharmaceutical rising 9.14% and WuXi Biologics increasing by 8.37% [5][21] - Hengrui Medicine's HRS9531 injection received acceptance for market approval from the National Medical Products Administration, targeting long-term weight management for adults with obesity-related conditions [12] Economic Indicators - China's August Manufacturing PMI rose to 50.5, surpassing market expectations of 49.5, indicating a recovery in manufacturing activity driven by increased new orders [13][14] - Hong Kong's retail sales value for July increased by 1.8% year-on-year, falling short of the expected 2.5% growth [10][11] IPO and Market Trends - Recent IPOs have shown strong performance, with Jiaxin International Resources listing at a price of HKD 33.82, reflecting a first-day gain of 177.84% [28] - The upcoming IPO of Daxing Technology is set for September 9, 2025, with a proposed offer price of HKD 49.5 [28] Sector Performance - The biotechnology sector led gains with a 3.58% increase, while the automotive sector saw a decline of 2.00% [24] - The pharmaceutical sector also performed well, contributing to the overall positive market sentiment [24]

Market Overview - On September 1, the Hong Kong stock market opened strongly, with the Hang Seng Index rising by 539 points or 2.2% to close at 25,617 points, driven by Alibaba's (9988 HK) performance [1] - The Hang Seng Tech Index also increased by 2.2%, closing at 5,798 points, with total market turnover exceeding 380.2 billion HKD and net inflow from the Stock Connect reaching 11.94 billion HKD [1] - Despite the overall rise, market breadth showed adjustments, with funds concentrating on technology, biomedicine, and non-ferrous metal stocks [1] Sector Performance - Alibaba's stock surged by 18.5% in a single day, marking the strongest increase among blue-chip stocks, with a trading volume of 54.92 billion HKD, the highest since its listing [1] - Semiconductor stocks also performed well, with SMIC (981 HK) rising by 4.9% due to increased capital expenditure in AI [1] - Biomedicine and non-ferrous metal stocks continued their strong performance, with Zijin Mining (2899 HK), Zhaojin Mining (1818 HK), and Luoyang Molybdenum (3993 HK) rising between 6.7% and 8.9% [1] Economic Indicators - The overall sentiment in the Hong Kong stock market remains stable, with active trading focused on high-performing stocks, indicating a structural market trend [2] - In August, China's official manufacturing PMI showed a slight recovery but remained in contraction territory, highlighting weak internal and external demand [2] - The non-manufacturing PMI also saw a minor increase, but the internal structure showed divergence, with the construction sector weakening and the service sector rebounding [2] Real Estate Dynamics - New home transaction volumes in major cities showed a year-on-year increase of 3.6% to 1.8 million square meters for the week ending August 31, indicating a recovery compared to the previous week [3] - Performance varied across city tiers, with first-tier cities seeing a decline of 5.1%, while second-tier cities experienced a growth of 17.7% [3] Automotive Sector Insights - The automotive sector lagged behind technology stocks, with BYD (1211 HK) reporting a net profit of 6.4 billion RMB for Q2, down 30% year-on-year and 31% quarter-on-quarter, below expectations [4] - Intense price competition has compressed profit margins, with a gross margin of 16.3% in Q2, down 3.8 percentage points [4] - The market is focused on BYD's overseas expansion, with production capacity in Indonesia, Brazil, and Hungary expected to be completed ahead of schedule [4] Healthcare Sector Developments - The Hang Seng Healthcare Index surged by 4.9%, led by innovative drugs and the CXO sector [4] - Most leading innovative drug companies reported strong interim results, while traditional pharmaceutical and medical device sectors continue to be affected by centralized procurement policies [4] Renewable Energy and Utilities - Recent performance in the renewable energy and utilities sector was mixed, with nuclear, gas, and environmental sectors generally declining, while solar and thermal power sectors saw gains [5] - Xinyi Solar (968 HK), Flat Glass (6865 HK), and GCL-Poly Energy (3800 HK) saw increases of 0.9%, 1.3%, and 2.4% respectively [5] Company-Specific Analysis: Innovent Biologics (1801 HK) - Innovent Biologics reported a 50.6% year-on-year increase in revenue to 5.95 billion RMB for the first half of the year, with a gross profit increase of 56.3% to 5.12 billion RMB [6] - The company successfully turned a profit with a net income of 830 million RMB, compared to a loss of 390 million RMB in the same period last year [6] - The main product, the oncology drug Darbepoetin, saw a 16% increase in sales revenue to approximately 2.7 billion USD (about 19.6 billion RMB) [6] Future Projections for Innovent Biologics - Sales revenue is expected to grow rapidly from 2025 to 2027, driven by the anticipated approval of new indications for existing products and the launch of new drugs [7] - The company plans to increase R&D investment, projecting over 300 million USD for the year, with expectations for net profit to significantly exceed previous forecasts [7] - Long-term prospects for pipeline products IBI363 and IBI343 are promising, with ongoing clinical trials showing positive results [8] Target Price and Rating Adjustments for Innovent Biologics - The target price for Innovent Biologics has been raised to 113.75 HKD, with a rating upgrade to "Buy" based on revised revenue forecasts and profit expectations [9]

Group 1: Market Overview - On September 1st, the Hong Kong stock market started well, with the Hang Seng Index rising 539 points or 2.2% to close at 25,617 points, and the Hang Seng Tech Index rising 2.2% to close at 5,798 points. The market turnover reached over HK$380.2 billion, and the Hong Kong Stock Connect had a net inflow of HK$11.94 billion [1] - The overall sentiment of the Hong Kong stock market remained stable, with active trading. The market presented a structural trend, mainly trading around high - performance stocks. The Hong Kong stock market is likely to continue to fluctuate at a high level. It is recommended to focus on technology leaders with high performance certainty, semiconductor, AI and computing infrastructure, and cyclical sectors such as non - ferrous metals [2] Group 2: Macro - dynamics - In the real estate sector, the volume of new home sales in 30 large and medium - sized cities reached 1.8 million square meters last week (as of August 31st), a year - on - year increase of 3.6%, better than the 9.2% year - on - year decline in the previous week, and a month - on - month increase of 11.6%, worse than the 26.2% month - on - month decline in the previous week. The year - on - year performance of different types of cities was divergent [3] Group 3: Industry Dynamics Automobile - In the automobile sector, BYD's second - quarter net profit was RMB 6.4 billion, a year - on - year decrease of 30% and a month - on - month decrease of 31%, lower than expected. The gross profit margin in the second quarter was 16.3%, a month - on - month decrease of 3.8 percentage points. The market has lowered its target price, and the stock price fell 5.2% on Monday to a three - month low. The market is focusing on the company's overseas expansion progress [4] Healthcare - The Hang Seng Healthcare Index rose 4.9% yesterday, led by the innovative drug and CXO sectors. The performance of innovative drug leading enterprises was mostly excellent, the CXO sector was recovering, while the traditional pharmaceutical and traditional medical device sectors were still affected by centralized procurement, and the performance of the medical service sector was still affected by medical insurance cost control [4] New Energy and Utilities - The performance of new energy and utility stocks in Hong Kong was divergent. The photovoltaic, thermal power, and Hong Kong utility sectors generally rose, while the nuclear power, gas, and environmental protection sectors generally fell [5] Group 4: Research Report on Xinda Bio - pharm (1801 HK) - In the first half of 2025, Xinda Bio - pharm's performance greatly exceeded expectations. The company's revenue in the first half of the year increased by 50.6% year - on - year to RMB 5.95 billion, and the gross profit increased by 56.3% year - on - year to RMB 5.12 billion, successfully turning losses into profits [6] - It is expected that the company's product sales revenue will grow rapidly from 2025 - 2027E. The profit in the second half of the year is expected to be significantly lower than that in the first half but still greatly exceed expectations. The net profit of shareholders from 2026 - 2027E is also expected to exceed expectations [7] - In the long run, in - research products such as IBI363 and IBI343 are expected to bring new highlights. As of the end of June, the company had 21 in - research products [8] - The target price is raised to HK$113.75, and the rating is upgraded to "Buy" [9] Group 5: Research Report on GUOQUAN FOOD (2517 HK) - GUOQUAN FOOD is China's dominant one - stop provider of at - home meal solutions. By the end of 2024, the number of its retail stores reached 10,150, leading the nearly RMB 400 billion market with a 3% share [10] - After the restructuring of the sales network, the number of stores has stabilized at over 10,000, and it is expected to have a net increase of 780 stores in 2025. The future strategy will prioritize lower - tier markets for expansion [11] - The company has built a strong supply chain moat, pioneering a 'single product, single factory' upstream supply chain cooperation model [12] - The report initiates coverage with a "Buy" rating and a target price of HK$5.17, forecasting a revenue CAGR of 22.2% from 2025 to 2027E [13]

Group 1: Market Performance - A-shares opened higher and closed higher, with the Shanghai Composite Index rising 0.46% to 3875.53 points, the Shenzhen Component Index rising 1.05%, and the ChiNext Index rising 2.29%. Precious metals and downstream jewelry all rose, and the healthcare industry led the market, while insurance led the decline [1]. - Hong Kong stocks rebounded weakly, with the Hang Seng Index rising 2.15% to 25617.42 points, the Hang Seng Tech Index rising 2.2%, and the Hang Seng China Enterprises Index rising 1.95%. Precious metals, energy, and healthcare industries pulled up, and Alibaba led the gains in the Hang Seng Index. The market turnover was HK$38.0231 billion [1]. - European stock markets closed slightly higher. U.S. stocks were closed on September 1 due to the Labor Day holiday [1]. Group 2: Macroeconomic Events - Trump said India's offer to reduce tariffs to zero was too late. Brazil's President Lula is convening a video conference of BRICS leaders to discuss Trump's trade policies [8][12]. - The Shanghai Cooperation Organization agreed to establish a development bank at its summit in Tianjin, and President Xi Jinping promised to increase investment and loans to partners [8][12]. - U.S. Treasury Secretary Bessent said the Trump administration may declare a national housing emergency in the fall and may consider tariff exemptions for specific building materials [8][12]. Group 3: Company News IPO and Listing - Dahon manufacturer DAHON TECHNOLOGY (2543) is offering 7.92 million shares for global sale, with a maximum fundraising of HK$392 million. It has introduced cornerstone investors subscribing for HK$99.6831 million, and is expected to list on September 9, 2025 [10]. - Easy Health Group submitted a listing application, aiming to list on the Main Board of the Hong Kong Stock Exchange. Its net profit in the first half of the year increased 4.38 times year-on-year [10]. - Hesai Technology passed the Hong Kong Stock Exchange's listing hearing and is rumored to raise over HK$2.3 billion [10]. - China Yipin Dairy is considering an IPO in Hong Kong, raising about US$100 million [10]. Company Operations and Developments - Kuaishou - W repurchased 1.137 million shares for HK$83.716 million [14]. - Geely Auto's total sales in August increased by about 38% year-on-year, and the total sales in the first eight months increased by 47% [14]. - NIO - SW delivered 31,305 vehicles in August, a year-on-year increase of 55.2% [14]. - Liaoning Port Co., Ltd. completed a share repurchase of RMB545 million for 334 million shares, and its controlling shareholder Dalian Port increased its stake by RMB230 million [14]. - New Town Development issued new shares to an Australian company, raising a net of HK$49.4 million for the development of tokenization technology [14]. - Sihuan Pharmaceutical partnered with Shenyuan Pharmaceutical to establish an AI R & D company [14]. - Stone Pharmaceutical Group's gout treatment drug passed the consistency evaluation of the National Medical Products Administration [14]. Group 4: Industry Data PMI Data - China's manufacturing PMI in August was 49.4, the non - manufacturing PMI was 50.3, and RatingDog's China manufacturing PMI was 50.5 [17]. - The U.S. manufacturing PMI in August was 53.3 (final value), and the service PMI was 55.4 (final value) [17]. Other Economic Data - The U.S. personal income and expenditure in July increased by 0.4% and 0.5% month - on - month respectively [17]. - The U.S. PCE price index in July was 2.6% year - on - year, and the core PCE price index was 2.9% year - on - year [17]. Group 5: Stock Quotes Hong Kong Stocks - Stocks such as Alibaba - SW, CStone Pharmaceuticals, and WuXi Biologics had different price changes and related indicators [18][20][23]. - Some small - and medium - cap stocks had significant price increases, such as International Commercial Settlement with a 97.25% increase [24]. U.S. Stocks - Stocks like UnitedHealth, PepsiCo, and Johnson & Johnson had different price changes and related indicators [28]. A - shares - Stocks such as Source Photonics, Wuxi AppTec, and Industrial Fubon had different price changes and trading volumes [30][31][33].

Market Overview - In September, the Chinese stock market opened positively, with A-shares rising, led by gold stocks; the Hang Seng Index experienced fluctuations, with Alibaba (9988 HK) surging 18.5% due to strong earnings[3] - European stock markets closed higher, driven by defense and healthcare sectors; US markets were closed for Labor Day[3][9] Currency and Commodities - The USD/CNY exchange rate reached a year-low of 7.126 on August 29, indicating a strong short-term outlook for the RMB, although further catalysts are needed for it to break below 7[5] - Oil traders expect OPEC+ to maintain current production levels in their upcoming meeting, with crude oil futures showing slight fluctuations[3][27] Fixed Income - US financial markets were quiet due to the holiday, with optimistic sentiment regarding a potential Fed rate cut this month; European bond yields rose amid positive economic data[3][30] - Asian bond markets saw light trading, with Chinese investment-grade bond spreads remaining stable[3] Stock Performance - The A-share market saw the Shanghai Composite Index rise 0.46% to 3,875 points, with a total trading volume of CNY 2.78 trillion; gold futures hit historical highs, boosting gold stocks significantly[17] - In the Hong Kong market, the Hang Seng Index increased by 2.15%, with major tech stocks leading the gains[11] Sector Insights - The electronics sector is experiencing robust growth driven by strong AI demand and domestic substitution; key segments include PCB, domestic chip leaders, and IoT[20] - In the US, companies are absorbing tariff costs rather than passing them on to consumers, which may lead to localized price increases in consumer goods later this year[8]

Group 1 - New World Development clarifies that it has not received any funding injection proposals as speculated by media reports, and is only in discussions for a loan financing arrangement led by Deutsche Bank AG [1] - The Zheng family of New World Development is reportedly considering a funding injection for the company by the end of 2025, following a delay in the payment of a $3.4 billion perpetual bond and ongoing liquidity issues [2] Group 2 - Yuzhou Group has successfully completed a debt restructuring that resolves approximately $6.68 billion in offshore debt, reducing its debt burden by about $3.5 billion, with no rigid repayment pressure until the end of 2026 [2] - In the first half of 2025, Yuzhou Group reported contract sales of 3.729 billion yuan, a year-on-year decrease of 14.21%, with a sales area of 254,600 square meters, down 8.85% from the previous year [3] Group 3 - The Shanghai Stock Exchange issued a written warning to Changsha Xingcheng Development Group for inaccuracies in its periodic report disclosures, which included corrections to financial statements from 2021 to 2024 [3] - Changsha Xingcheng has 11 outstanding bonds totaling 7.08 billion yuan [3] Group 4 - Fujian Sunshine Group reported multiple asset restrictions, including equity freezes totaling approximately 374 million yuan, with most restrictions lasting two to three years [4] - Fujian Sunshine Group has seven outstanding offshore bonds with a total balance of $1.3919 billion, all of which are in default [4]

Market Overview - The Hang Seng Index is facing resistance at 26,000 points, influenced by the extension of the US-China tariff truce and the Federal Reserve's potential policy adjustments due to changing risk balances [2][5] - The overall market is active with a positive risk appetite, and capital is rotating among different sectors [2] Company News - JD Group (9618) has made a takeover offer for CECONOMY, with the acceptance period until November 10 [4][10] - BYD (1211) reported a 0.2% increase in August vehicle sales, totaling 373,600 units [10] - Xiaomi (1810) delivered over 30,000 vehicles in August and opened 18 new stores [10] - China Merchants Bank (3968) is working on anti-competitive measures under regulatory guidance [4] - Shandong Gold (1787) raised 3.9 billion yuan through a discounted share placement to repay debts [4] Economic Indicators - The S&P Global Manufacturing PMI for China rose to 50.5 in August, indicating a recovery in manufacturing activity [7][8] - The average price of second-hand residential properties in 100 cities in China fell by 0.76% month-on-month in August, while new residential prices saw a slight increase [8] - Hong Kong's retail sales increased by 1.8% in July, although this was below market expectations [8] Sector Focus - The smartphone parts sector is entering a traditional peak season with major brands set to launch new devices [7] - The AI and robotics sectors are seeing increased activity, with advancements in humanoid robots and smart glasses [7] Stock Market Performance - The Hang Seng Index closed at 25,617, up 2.15%, with a total market turnover of 380.2 billion HKD [6] - The Hang Seng Tech Index rose by 2.20%, reflecting strong performance in technology stocks [6] International Market Insights - The US Federal Reserve is expected to maintain a cautious approach to interest rate cuts, with projections indicating two rate cuts totaling 50 basis points this year [5] - Global trade negotiations are ongoing, with some progress reported, but uncertainties remain [5]